Bajaj Electricals Limited has informed the Exchange about Credit Rating
Eris Lifesciences Limited has informed the Exchange regarding .UPDATE ON ANNOUNCEMENT UNDER REGULATION 30 (LODR) - JOINT VENTURE
UPL Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
Vikas Lifecare Limited has informed the Exchange regarding Vikas Lifecare acquired 75% stake in Genesis Gas Solutions Private Limited.
Indo Count Industries Limited has informed the Exchange about Loss of Share Certificates bearing folio number 0046354
Banaras Beads Limited has informed the Exchange about Copy of Newspaper Publication
United Spirits Limited has informed the Exchange about Loss of Share Certificates
JITF Infralogistics Limited has informed the Exchange about Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018
Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated January 14, 2022, titled Glenmark Specialty S.A. (Switzerland) receives NDA Approval by the United States Food and Drug Administration (FDA) for Ryaltris Nasal Spray for the Treatment of Symptoms of Seasonal Allergic Rhinitis in Adults and Pediatric Patients 12 Years of Age and Older.
Dhunseri Investments Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.